Rhythm Pharmaceuticals
RP
RH
Rhythm Pharmaceuticals
Biopharmaceutical company focused on rare genetic diseases of obesity.
About
Rhythm Pharmaceuticals is a biopharmaceutical company dedicated to developing and commercializing therapies for patients with rare genetic diseases of obesity. Their lead product, IMCIVREE (setmelanotide), is approved in the U.S. and Europe for specific genetic forms of obesity.
Key facts
At-a-glance profile data
- Website
- rhythm.com
- Headquarters
- Boston, United States
- Founded
- 2008
- Total funding
- -
- Business model
- B2B
- Tags
- BiotechMedTechHealthTechDrug DiscoveryClinical Trials
Tech stack
Detected on rhythm.com, last scanned 9 Jun 2026. Run your own scan
- Email provider
- Microsoft 365
Add first review
Frequently asked
What is Rhythm Pharmaceuticals's current status?
Rhythm Pharmaceuticals's current operating status is: Inactive.